APH vs RNXT · P/E 40, rev $23.09B vs rev $266.0K
Amphenol Corporation (APH) versus RenovoRx Inc (RNXT) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. RNXT currently screens at market cap $47.0M.
Not investment advice. Open the APH and RNXT stock pages for the full models.
Not investment advice.